RecruitingNCT02872987
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Goethe University
- Principal Investigator
- Nicola Gökbuget, Dr. med.University Hospital of Frankfurt (Main)
- Enrollment
- 10000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2035
Study locations (30)
- Universitätsklinikum Graz, Graz, Austria
- LKH-Hochsteiermark Leoben, Leoben, Austria
- Hanusch-Krankenhaus Wien, Vienna, Austria
- University Hospital of Frankfurt (Main), Frankfurt am Main, Hesse, Germany
- Universitätsklinikum Aachen, Aachen, Germany
- Klinikum Altenburger Land, Altenburg, Germany
- Kreiskliniken Altötting, Altötting, Germany
- Klinikum Aschaffenburg, Aschaffenburg, Germany
- Klinikum Augsburg, Augsburg, Germany
- Helios Klinikum Bad Saarow, Bad Saarow, Germany
- Sozialstiftung Bamberg, Bamberg, Germany
- Klinikum Bayreuth, Bayreuth, Germany
- Alexianer St. Hedwig Krankenhaus, Berlin, Germany
- Charité Universitätsmedizin Berlin, Berlin, Germany
- Evangelisches Waldkrankenhaus Spandau, Berlin, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02872987 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT07328503CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University